Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis

Neil Gittoes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBone
Publication statusAccepted/In press - 3 Oct 2019

Cite this